TEM logo
TEM
Tempus AI

AstraZeneca And Pathos Partnership Will Expand Precision Medicine

AN
AnalystConsensusTarget
AnalystConsensusTarget
Not Invested
Consensus Narrative from 10 Analysts
Published
15 Jun 25
Updated
24 Jul 25
AnalystConsensusTarget's Fair Value
US$66.77
13.5% undervalued intrinsic discount
24 Jul
US$57.74
Loading
1Y
42.0%
7D
-0.9%

Author's Valuation

US$66.8

13.5% undervalued intrinsic discount

AnalystConsensusTarget Fair Value